Why the Medical Cannabis Market Is Entering a Growth .Surgehttps://www.marketresearchfuture.com/reports/medical-cannabis-market-8368
According to Market Research Future, the global Medical Cannabis Market is projected to grow significantly — from a 2024 valuation of around USD 18.74 billion to nearly USD 49.99 billion by 2035, registering a compound annual growth rate (CAGR) of 9.33% between 2025 and 2035.
This growth is being driven by several converging factors:
Increase in Research & Therapeutic Acceptance — There is growing scientific and clinical research supporting cannabis-derived medicines for a range of conditions including chronic pain, neurological disorders, mental health issues, appetite loss, and more.
Regulatory Changes & Global Adoption Trend — As more jurisdictions update their regulatory frameworks to permit medical-use cannabis, patient access is expanding, making medical cannabis a more viable and accepted therapeutic option.
Demand for Alternative & Holistic Treatments — With rising chronic disease burden, ageing populations and concerns about side-effects of conventional drugs, patients are increasingly looking at natural or plant-based therapies, giving a boost to cannabis-based medical products.
What This Means for Stakeholders (Healthcare, Pharma, Policy, Investment)
For Patients & Healthcare Providers — Medical cannabis is gradually shifting from a niche or controversial remedy toward mainstream acceptance, offering an alternate route for pain management, neurological conditions, and symptom relief, especially where conventional therapies fall short.
For Pharma & Biotech Firms — The growing market underscores a strong opportunity for development of cannabinoid-based therapeutics, novel formulations, clinical trials, and regulated, quality-assured cannabis products.
For Regulators & Policymakers — The evolving global legal framework highlights the need for robust regulations ensuring safety, quality, standardized dosing, and education — as medical cannabis adoption increases.
For Investors & Market Watchers — With a nearly 3× projected market growth by 2035, the medical cannabis sector represents a promising long-term investment area — especially where regulatory clarity and scientific backing converge.
In short: The Medical Cannabis Market is no longer a fringe phenomenon — it’s evolving rapidly, attracting legitimacy, innovation, and capital.
For a deeper dive, access the full report here: https://www.marketresearchfuture.com/reports/medical-cannabis-market-8368
Sample FAQs
Q1. What is “medical cannabis” and how does it differ from recreational cannabis?
Medical cannabis refers to the cannabis plant and its derivatives (e.g. oils, tinctures) used under medical supervision to treat or manage specific medical conditions — such as chronic pain, neurological disorders, appetite loss — rather than for recreational or non-therapeutic use. Its cultivation, production, and usage are subject to regulatory approvals and clinical standards.
Q2. Why is the medical cannabis market expected to grow so rapidly over the next decade?
The growth is driven by increasing scientific research supporting therapeutic benefits of cannabinoids, rising patient demand for alternative treatments
According to Market Research Future, the global Medical Cannabis Market is projected to grow significantly — from a 2024 valuation of around USD 18.74 billion to nearly USD 49.99 billion by 2035, registering a compound annual growth rate (CAGR) of 9.33% between 2025 and 2035.
This growth is being driven by several converging factors:
Increase in Research & Therapeutic Acceptance — There is growing scientific and clinical research supporting cannabis-derived medicines for a range of conditions including chronic pain, neurological disorders, mental health issues, appetite loss, and more.
Regulatory Changes & Global Adoption Trend — As more jurisdictions update their regulatory frameworks to permit medical-use cannabis, patient access is expanding, making medical cannabis a more viable and accepted therapeutic option.
Demand for Alternative & Holistic Treatments — With rising chronic disease burden, ageing populations and concerns about side-effects of conventional drugs, patients are increasingly looking at natural or plant-based therapies, giving a boost to cannabis-based medical products.
What This Means for Stakeholders (Healthcare, Pharma, Policy, Investment)
For Patients & Healthcare Providers — Medical cannabis is gradually shifting from a niche or controversial remedy toward mainstream acceptance, offering an alternate route for pain management, neurological conditions, and symptom relief, especially where conventional therapies fall short.
For Pharma & Biotech Firms — The growing market underscores a strong opportunity for development of cannabinoid-based therapeutics, novel formulations, clinical trials, and regulated, quality-assured cannabis products.
For Regulators & Policymakers — The evolving global legal framework highlights the need for robust regulations ensuring safety, quality, standardized dosing, and education — as medical cannabis adoption increases.
For Investors & Market Watchers — With a nearly 3× projected market growth by 2035, the medical cannabis sector represents a promising long-term investment area — especially where regulatory clarity and scientific backing converge.
In short: The Medical Cannabis Market is no longer a fringe phenomenon — it’s evolving rapidly, attracting legitimacy, innovation, and capital.
For a deeper dive, access the full report here: https://www.marketresearchfuture.com/reports/medical-cannabis-market-8368
Sample FAQs
Q1. What is “medical cannabis” and how does it differ from recreational cannabis?
Medical cannabis refers to the cannabis plant and its derivatives (e.g. oils, tinctures) used under medical supervision to treat or manage specific medical conditions — such as chronic pain, neurological disorders, appetite loss — rather than for recreational or non-therapeutic use. Its cultivation, production, and usage are subject to regulatory approvals and clinical standards.
Q2. Why is the medical cannabis market expected to grow so rapidly over the next decade?
The growth is driven by increasing scientific research supporting therapeutic benefits of cannabinoids, rising patient demand for alternative treatments
🌿 Why the Medical Cannabis Market Is Entering a Growth .Surgehttps://www.marketresearchfuture.com/reports/medical-cannabis-market-8368
According to Market Research Future, the global Medical Cannabis Market is projected to grow significantly — from a 2024 valuation of around USD 18.74 billion to nearly USD 49.99 billion by 2035, registering a compound annual growth rate (CAGR) of 9.33% between 2025 and 2035.
This growth is being driven by several converging factors:
Increase in Research & Therapeutic Acceptance — There is growing scientific and clinical research supporting cannabis-derived medicines for a range of conditions including chronic pain, neurological disorders, mental health issues, appetite loss, and more.
Regulatory Changes & Global Adoption Trend — As more jurisdictions update their regulatory frameworks to permit medical-use cannabis, patient access is expanding, making medical cannabis a more viable and accepted therapeutic option.
Demand for Alternative & Holistic Treatments — With rising chronic disease burden, ageing populations and concerns about side-effects of conventional drugs, patients are increasingly looking at natural or plant-based therapies, giving a boost to cannabis-based medical products.
💡 What This Means for Stakeholders (Healthcare, Pharma, Policy, Investment)
For Patients & Healthcare Providers — Medical cannabis is gradually shifting from a niche or controversial remedy toward mainstream acceptance, offering an alternate route for pain management, neurological conditions, and symptom relief, especially where conventional therapies fall short.
For Pharma & Biotech Firms — The growing market underscores a strong opportunity for development of cannabinoid-based therapeutics, novel formulations, clinical trials, and regulated, quality-assured cannabis products.
For Regulators & Policymakers — The evolving global legal framework highlights the need for robust regulations ensuring safety, quality, standardized dosing, and education — as medical cannabis adoption increases.
For Investors & Market Watchers — With a nearly 3× projected market growth by 2035, the medical cannabis sector represents a promising long-term investment area — especially where regulatory clarity and scientific backing converge.
In short: The Medical Cannabis Market is no longer a fringe phenomenon — it’s evolving rapidly, attracting legitimacy, innovation, and capital.
For a deeper dive, access the full report here: https://www.marketresearchfuture.com/reports/medical-cannabis-market-8368
🤔 Sample FAQs
Q1. What is “medical cannabis” and how does it differ from recreational cannabis?
Medical cannabis refers to the cannabis plant and its derivatives (e.g. oils, tinctures) used under medical supervision to treat or manage specific medical conditions — such as chronic pain, neurological disorders, appetite loss — rather than for recreational or non-therapeutic use. Its cultivation, production, and usage are subject to regulatory approvals and clinical standards.
Q2. Why is the medical cannabis market expected to grow so rapidly over the next decade?
The growth is driven by increasing scientific research supporting therapeutic benefits of cannabinoids, rising patient demand for alternative treatments
0 Commentaires
0 Parts
207 Vue
0 Aperçu